alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### Robert H. BASS, Petitioner, v. Togo D. WEST, Jr., Secretary of Veterans Affairs, Respondent.

No. 98-1288.

United States Court of Veterans Appeals.

Sept. 23, 1998.

Before FARLEY, STEINBERG, and GREENE, Judges.

ORDER

PER CURIAM:

On August 10, 1998, in a single-judge order, the Court denied the petitioner’s petition for extraordinary relief in the nature of mandamus. On August 17, 1998, the petitioner filed a timely motion for reconsideration and, in the alternative, for review by a panel or the full Court, which the Court construes to be a motion for a panel decision.

Upon consideration of the foregoing, it is by the single judge

ORDERED that the motion for reconsideration is DENIED. It is by the panel

ORDERED that the motion for a panel decision is DENIED'.

STEINBERG, Judge,

concurring:

Although I voted to deny the petitioner’s motion for panel decision, I note that he raises in his motion a question of whether the Department of Veterans Affairs has impeded action on his other claims by removing his claims file from the regional office (RO) without leaving copies for the RO to use in working on his other claims. In *Perry v. West,*the Court rebuked the Secretary for such delays “in light of the assurances provided to the Court in *Neumann [v. Brown,*U.S. Vet.App. No. 96-1726], as to ‘earlier release of claims file by the [General Counsel’s Office] and strategic copying of the claims files by the ROs and the Board [of Veterans’ Appeals] for use in remands and motions for reconsideration’ and as to the return of claims files to ROs as soon as *433possible after the 30-day period for supplementing the [record on appeal] has expired in a particular case.” *Perry,*11 Vet.App. 319, 333 (1998) (quoting *Neumann*(Secretary’s Response filed May 9, 1997, at 6)). Although the Court cannot address the petitioner’s concerns here because he first raised this issue after the Court had ruled on his case, *see Savage v. Gober,*10 Vet.App. 488, 498 (1997), had the petitioner complained initially, I would have voted to require the Secretary to respond, as did the Court in *Perry,*to the petitioner’s allegations. *Perry,*11 Vet.App. at 332.
**Exhibit 32.2**
Certification Pursuant to 18 U.S.C. Section 1350.
In connection with the Quarterly Report of Front Range Capital Corporation (the“Company”) on Form 10-Q for the period ending September 30, 2004 as filed withthe Securities and Exchange Commission on the date hereof (the “Report”), I,Alice M. Voss, Chief Financial Officer of the Company, certify, pursuant to 18U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-OxleyAct of 2002, that:
 (1) The Report fully complies with the requirements of section13(a) or 15(d) of the Securities Exchange Act of 1934; and  (2) The information contained in the Report fairly presents, inall material respects, the financial condition and results ofoperations of the Company.    /s/ Alice M. Voss   Alice M. VossChief Financial Officer
A signed original of this written statement required by Section 906 has beenprovided to Front Range Capital and will be retained by Front Range CapitalCorporation and furnished to the Securities and Exchange Commission or itsstaff upon request.
**Exhibit 32**

** **

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 ASADOPTED**

**PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF2002**

 

Thecertifications set forth below are hereby submitted to the Securities andExchange Commission pursuant to, and solely for the purpose of complying with, Section 1350of Chapter 63 of Title 18 of the United States Code in connection with thefiling on the date hereof with the Securities and Exchange Commission of theQuarterly Report on Form 10-Q of the Company for the quarter ended March 31,2009.

 

Eachof the undersigned hereby certifies in his capacity as an officer of CitizensBancshares Corporation and subsidiary (the “Company”) that, to his knowledge onthe date of this certification, the Quarterly Report of the Company on Form 10-Qfor the period ended March 31, 2009 fully complies with the requirementsof Section 13(a) or 15(d) of the Securities Exchange Act of 1934and that the information contained in such report fairly presents, in allmaterial respects, the financial condition of the Company at the end of suchperiod and the results of operations of the Company for such period.

 

 
| Date:  | May 15, 2009 | By:                                   | /s/ James E. Young |
|--------|-------------------|---------------------------------------|--------------------|
|   |              | James E. Young                        |
|   |              | President and Chief Executive Officer |
|   |              |                                  |
|   |              |                                  |
| Date:  | May 15, 2009 | By:                                   | /s/ Cynthia N. Day |
|   |              | Cynthia N. Day                        |
|   |              | Senior Executive Vice President and   |
|   |              | Chief Operating Officer               |
|   |              |                                  |
|   |              |                                  |
| Date:  | May 15, 2009 | By:                                   | /s/ Samuel J. Cox  |
|   |              | Samuel J. Cox                         |
|   |              | Executive Vice President and          |
|   |              | Chief Financial Officer               |

 

----
Editorial Note on Part 112
Editorial Note: Nomenclature changes to part 112 appear at 81 FR 49896, July 29, 2016.

§ 112.201 Under what circumstances can FDA withdraw a qualified exemption in accordance with the requirements of § 112.5? ( a ) We may withdraw your qualified exemption under § 112.5: ( 1 ) In the event of an active investigation of a foodborne illness outbreak that is directly linked to your farm; or
( 2 ) If we determine that it is necessary to protect the public health and prevent or mitigate a foodborne illness outbreak based on conduct or conditions associated with your farm that are material to the safety of the food that would otherwise be covered produce grown, harvested, packed or held at your farm.
( b ) Before FDA issues an order to withdraw your qualified exemption, FDA: ( 1 ) May consider one or more other actions to protect the public health and prevent or mitigate a foodborne illness outbreak, including a warning letter, recall, administrative detention, refusal of food offered for import, seizure, and injunction;
( 2 ) Must notify the owner, operator, or agent in charge of the farm, in writing, of circumstances that may lead FDA to withdraw the exemption, and provide an opportunity for the owner, operator, or agent in charge of the farm to respond in writing, within 15 calendar days of the date of receipt of the notification, to FDA's notification; and
( 3 ) Must consider the actions taken by the farm to address the circumstances that may lead FDA to withdraw the exemption.
38766.

#### BRANNEN v. CUBBEDGE *et al.,*Executors.

Nichols, Judge.

On October 11, 1960, the trial court overruled the defendant’s motion-for new trial and for a judgment non obstante veredicto. On November 8, I960, the -defendant tendered his bill of exceptions to the trial court for certification, counsel for the plaintiffs having waived notice of such presentation on the same date. On December 28, 1960, the *553trial court certified the writ of error and on January 4, 1961, counsel for the plaintiffs acknowledged sendee of such writ of error. *Held:*

Decided April 5, 1961

Rehearing denied April 24, 1961.

*David H. Fritts,*for plaintiff in error.

*Robert E. Falligant,*contra.

1. Under the decisions of the Supreme Court in the cases of *Duke v. Kelly,*136 Ga. 832, 833 (72 S. E. 250); *Clay v. Floyd,*208 Ga. 374 (66 S. E. 2d 916); *Bostic v. Nesbitt,*209 Ga. 159 (71 S. E. 2d 213); *Gilbert v. Moody,*209 Ga. 637 (74 S. E. 2d 879); *Moore v. Moore,*215 Ga. 47 (2) (108 S. E. 2d 704); *Walton v. Chatham,*215 Ga. 683 (113 S. E. 2d 125); *Jarvis v. Risner,*215 Ga. 684 (113 S. E. 2d 126), and similar cases, the writ of error must be dismissed, for no reason appears in. the certificate, nor is any shown in the record, for the delay in certification, and counsel for the plaintiff in error have made no effort to obtain a mandamus from this court to compel the judge to certify the bill of exceptions.

2. The decision in the case of *Buice v. Bryan,*212 Ga. 508 (1) (93 S. E. 2d 676), where the bill of exceptions was held by the trial judge for forty-five days, does not authorize a different judgment, for in that case the only party harmed by the delay was the plaintiff in error who was in jail, and the Supreme Court held that for such reason an exception to the general rule existed.

*Writ of error dismissed.*

*Felton, C. J., and Bell, J., concur.*
EXHIBIT
32.1





CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER





Pursuant
to Section 906 of the Sarbanes Oxley Act of 2002 (18 U.S.C. 1350)
and


Rules
13a-14(b) of the Securities Exchange Act of 1934





I, Keith
A. Meister, Principal Executive Officer of Icahn Enterprises G.P. Inc., the
general partner of Icahn Enterprises L.P. (the “Registrant”), certify that, to
the best of my knowledge, based upon a review of the Icahn Enterprises L.P.
quarterly report on Form 10-Q for the period ended March 31, 2010 of the
Registrant (the “Report”):




(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and




(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Registrant.




/s/  Keith
      A. MeisterKeith
      A. MeisterPrincipal
      Executive Officer and Vice Chairman of the Board of Icahn Enterprises G.P.
      Inc., the general partner of Icahn Enterprises L.P.


Date: May
6, 2010
Exhibit
32
 Certification
of Periodic Financial Report
 Pursuant
to 18 U.S.C. Section 1350


Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, each of the undersigned officers of AMCOL
International Corporation (the “Company”) certifies that the quarterly report on
Form 10-Q/A of the Company for the three months ended September 30, 2008 fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 and information contained in that Form 10-Q fairly
presents, in all material respects, the financial condition and results of
operations of the Company.





Date: 
      March 13, 2009
                    /s/ Lawrence E. WashowLawrence
      E. Washow
                      Chief
      Executive OfficerDate: 
      March 13, 2009
                    /s/ Donald W. PearsonDonald
      W. Pearson
                      Chief
      Financial
Officer


50
§ 208.24 Distributing and dispensing a Medication Guide. ( a ) The manufacturer of a drug product for which a Medication Guide is required under this part shall obtain FDA approval of the Medication Guide before the Medication Guide may be distributed.
( b ) Each manufacturer who ships a container of drug product for which a Medication Guide is required under this part is responsible for ensuring that Medication Guides are available for distribution to patients by either: ( 1 ) Providing Medication Guides in sufficient numbers to distributors, packers, or authorized dispensers to permit the authorized dispenser to provide a Medication Guide to each patient receiving a prescription for the drug product; or
( 2 ) Providing the means to produce Medication Guides in sufficient numbers to distributors, packers, or authorized dispensers to permit the authorized dispenser to provide a Medication Guide to each patient receiving a prescription for the drug product.
( c ) Each distributor or packer that receives Medication Guides, or the means to produce Medication Guides, from a manufacturer under paragraph (b) of this section shall provide those Medication Guides, or the means to produce Medication Guides, to each authorized dispenser to whom it ships a container of drug product.
( d ) The label of each container or package, where the container label is too small, of drug product for which a Medication Guide is required under this part shall instruct the authorized dispenser to provide a Medication Guide to each patient to whom the drug product is dispensed, and shall state how the Medication Guide is provided. These statements shall appear on the label in a prominent and conspicuous manner.
( e ) Each authorized dispenser of a prescription drug product for which a Medication Guide is required under this part shall, when the product is dispensed to a patient (or to a patient's agent), provide a Medication Guide directly to each patient (or to the patient's agent) unless an exemption applies under § 208.26.
( f ) An authorized dispenser or wholesaler is not subject to section 510 of the Federal Food, Drug, and Cosmetic Act, which requires the registration of producers of drugs and the listing of drugs in commercial distribution, solely because of an act performed by the authorized dispenser or wholesaler under this part.
```

[Federal Register Volume 76, Number 198 (Thursday, October 13, 2011)]
[Notices]
[Page 63665]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-26485]

-----------------------------------------------------------------------

NATIONAL FOUNDATION ON THE ARTS AND THE HUMANITIES

Federal Council on the Arts and the Humanities Arts and Artifacts 
Indemnity Panel Advisory Committee

AGENCY: The National Endowment for the Humanities.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

    Pursuant to the provisions of the Federal Advisory Committee Act 
(Pub. L. 92-463 as amended) notice is hereby given that a meeting of 
the Arts and Artifacts Indemnity Panel of the Federal Council on the 
Arts and the Humanities will be held at 1100 Pennsylvania Avenue, NW., 
Washington, DC 20506, in Room 817, from 9:30 a.m. to 5 p.m., on 
Thursday, November 3, 2011.
    The purpose of the meeting is to review applications for 
Certificates of Indemnity submitted to the Federal Council on the Arts 
and the Humanities for exhibitions beginning after January 1, 2012.
    Because the proposed meeting will consider financial and commercial 
data and because it is important to keep values of objects, methods of 
transportation and security measures confidential, pursuant to the 
authority granted me by the Chairman's Delegation of Authority to Close 
Advisory Committee Meetings, dated July 19, 1993, I have determined 
that the meeting would fall within exemption (4) of 5 U.S.C. 552(b) and 
that it is essential to close the meeting to protect the free exchange 
of views and to avoid interference with the operations of the 
Committee.
    It is suggested that those desiring more specific information 
contact Advisory Committee Management Officer, Elizabeth Voyatzis, 1100 
Pennsylvania Avenue, NW., Washington, DC 20506, or call 202-606-8322.

Elizabeth Voyatzis,
Advisory Committee, Management Officer.
[FR Doc. 2011-26485 Filed 10-12-11; 8:45 am]
BILLING CODE 7536-01-P
```
### Waterpower resources of the Bradley River Basin, Kenai Peninsula, Alaska

By: F.A. Johnson

                            https://doi.org/10.3133/wsp1610A

#### Links

-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report**                                                                                                     (pdf)                                                                                                                                     
- Plate:  **Plate 1**                            (pdf)
- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
§ 169.140 Mayonnaise. ( a ) *Description.* Mayonnaise is the emulsified semisolid food prepared from vegetable oil(s), one or both of the acidifying ingredients specified in paragraph (b) of this section, and one or more of the egg yolk-containing ingredients specified in paragraph (c) of this section. One or more of the ingredients specified in paragraph (d) of this section may also be used. The vegetable oil(s) used may contain an optional crystallization inhibitor as specified in paragraph (d)(7) of this section. All the ingredients from which the food is fabricated shall be safe and suitable. Mayonnaise contains not less than 65 percent by weight of vegetable oil. Mayonnaise may be mixed and packed in an atmosphere in which air is replaced in whole or in part by carbon dioxide or nitrogen.
( b ) *Acidifying ingredients.* ( 1 ) Any vinegar or any vinegar diluted with water to an acidity, calculated as acetic acid, of not less than 21 ⁄ 2 percent by weight, or any such vinegar or diluted vinegar mixed with an optional acidifying ingredient as specified in paragraph (d)(6) of this section. For the purpose of this paragraph, any blend of two or more vinegars is considered to be a vinegar.
( 2 ) Lemon juice and/or lime juice in any appropriate form, which may be diluted with water to an acidity, calculated as citric acid, of not less than 21 ⁄ 2 percent by weight.
( c ) *Egg yolk-containing ingredients.* Liquid egg yolks, frozen egg yolks, dried egg yolks, liquid whole eggs, frozen whole eggs, dried whole eggs, or any one or more of the foregoing ingredients listed in this paragraph with liquid egg white or frozen egg white.
( d ) *Other optional ingredients.* The following optional ingredients may also be used: ( 1 ) Salt.
( 2 ) Nutritive carbohydrate sweeteners.
( 3 ) Any spice (except saffron or turmeric) or natural flavoring, provided it does not impart to the mayonnaise a color simulating the color imparted by egg yolk.
( 4 ) Monosodium glutamate.
( 5 ) Sequestrant(s), including but not limited to calcium disodium EDTA (calcium disodium ethylenediamine- tetraacetate) and/or disodium EDTA (disodium ethylenediaminetetraacetate), may be used to preserve color and/or flavor.
( 6 ) Citric and/or malic acid in an amount not greater than 25 percent of the weight of the acids of the vinegar or diluted vinegar, calculated as acetic acid.
( 7 ) Crystallization inhibitors, including but not limited to oxystearin, lecithin, or polyglycerol esters of fatty acids.
( e ) *Nomenclature.* The name of the food is “Mayonnaise”.
( f ) *Label declaration.* Each of the ingredients used in the food shall be declared on the label as required by the applicable sections of parts 101 and 130 of this chapter.
[42 FR 14481, Mar. 15, 1977, as amended at 57 FR 34246, Aug. 4, 1992; 58 FR 2886, Jan. 6, 1993]
<PAGE>   1
                            [PERKINS COIE LLP LETTERHEAD]





                                  May 20, 1998



InControl, Inc.
6675 - 185th Ave. NE
Redmond, WA  98052

        RE:    REGISTRATION STATEMENT ON FORM S-3

Gentlemen and Ladies:

        We have acted as counsel to you in connection with the preparation of a
Registration Statement on Form S-3 (the "Registration Statement") under the
Securities Act of 1933, as amended (the "Act"), which you are filing with the
Securities and Exchange Commission for the resale of up to 4,733,142 shares of
Common Stock, $.01 par value (the "Shares"). We have examined the Registration
Statement and such documents and records of the Company and other documents as
we have deemed necessary for the purpose of this opinion.

        Based upon and subject to the foregoing, we are of the opinion that the
Shares have been duly authorized and are validly issued, fully paid and
nonassessable.

        We hereby consent to the filing of this opinion as an exhibit to the
Registration Statement. In giving such consent, we do not admit that we are in
the category of persons whose consent is required under Section 7 of the Act.

                                            Very truly yours,



                                            Perkins Coie LLP
December 3, 2015

Mr. Fabio Vieira

Accountable Manager

C&D Brasil LTDA

AV. Getulio Dornelles Vargas, 3000 – Corrego Seco

Jacarei – SP – Brazil, 12305-010

Dear Mr. Vieira:

This is in response to your August 12, 2015, letter sent to the public docket No. 

( FAA-2015-3974) petitioning the Federal Aviation Administration (FAA) on behalf of C&D 

Brasil LTDA for an exemption from Title 14, Code of Federal Regulations (14 CFR) section 

145.103(b). That exemption, if granted, would allow C&D Brasil LTDA to operate a repair 

station with an airframe rating without suitable permanent housing to enclose the largest type 

and model of aircraft listed on its operations specifications.

In your petition, you state that C&D Brasil LTDA seeks this exemption so it may be eligible 

for a part 145 certificate to allow C&D Brasil LTDA to work with interior aircraft 

components that will be shipped to C&D Brasil LTDA by the customer. The FAA cannot 

issue an exemption to a section in part 145 to a non-certificated petitioner who is not 

regulated by part 145, and therefore does not have authority to request that exemption. We 

will take no further action on your petition.

Sincerely,

/s/

John Barbagallo

Deputy Director, Flight Standards Service
Editorial Note on Part 184
Editorial Note: Nomenclature changes to part 184 appear at 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 69 FR 13717, Mar. 24, 2004; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; and 81 FR 49897, July 29, 2016.

§ 184.1911 Triethyl citrate. ( a ) Triethyl citrate (C12H20O7, CAS Reg. No. 77-93-0) is the triethyl ester of citric acid. It is prepared by esterifying citric acid with ethyl alcohol and occurs as an odorless, practically colorless, oily liquid.
( b ) The ingredient meets the specifications of the Food Chemicals Codex, 3d ed. (1981), p. 339, which is incorporated by reference in accordance with 5 U.S.C. 552(a) and 1 CFR part 51. Copies are available from the National Academy Press, 2101 Constitution Ave. NW., Washington, DC 20418, and the Center for Food Safety and Applied Nutrition (HFS-200), 5001 Campus Dr., College Park, MD 20740, or may be examined at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html .*
( c ) In accordance with § 184.1(b)(1), the ingredient is used in food with no limitation other than current good manufacturing practice. The affirmation of this ingredient as generally recognized as safe (GRAS) as a direct human food ingredient is based upon the following current good manufacturing practice conditions of use: ( 1 ) The ingredient is used as a flavoring agent as defined in § 170.3(o)(12) of this chapter; a solvent and vehicle as defined in § 170.3(o)(27) of this chapter; and a surface-active agent as defined in § 170.3(o)(29) of this chapter.
( 2 ) The ingredient is used in foods at levels not to exceed current good manufacturing practice.
( d ) Prior sanctions for this ingredient different from the uses established in this section, or different from those set forth in part 181 of this chapter, do not exist or have been waived.
[59 FR 63897, Dec. 12, 1994]